CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market sale Director sold 1,200,000 shares at $105.47 ($126,564,000)
- 4/A Open-market sale Director sold 5,908 shares at $287.46 ($1,698,314)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 4,000 shares at $117.88 ($471,520)
- 4 Open-market buy Chief Executive Officer bought 4,000 shares at $124.00 ($496,000)
- 4 Open-market buy Director bought 2,000 shares at an average $124.69 ($249,387)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Director acquired 20,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 12 of 29 · 564 filings